Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccineHeavy hearts soared Monday with news that Moderna's Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects.[Collection]

Heavy hearts soared Monday with news that Moderna's Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects.https://www.cnbc.com/2020/05/19/experts-say-moderna-didnt-produce-data-critical-to-assessing-vaccine.html